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GAS-LIQUID CHROMATOGRAPHY IN PHARMACOLOGY AND 
TOXICOLOGY
PHARMACOKINETIC AN ALYSIS LIM ITED B Y  THE SEN SITIVITY OF THE 
AN ALYTICAL TECHNIQUE
J. M. v a n  R O SSU M , D. D . B R E IM E R , G. A . M. v a n  G IN N E K E N , J. M. G. v a n  K O R D E L A A R  
a n d  T . B . V R E E
Department o f Pharmacology, Catholic University M edical School, Nijmegen (The Netherlands)
SUMMARY
A survey is given conserving the possibility of gas-chromatographic analysis 
of drugs. Attentión is paid to the plasma concentration curve, biological half-life 
and multicompartment kinetics.
The intensity óf a drug-induced effect in man depends on the affinity to specific 
receptors and the concentration of such a chemical in the target tissue. This drug 
concentration in the receptor compartment is a function of the concentration in the 
blood or plasma.
Although in almost all cases the drug concentration in the target tissue cannot 
be assessed directly, the plasma concentration may be measured, provided that 
sensitive analytical techniques are available.
The plasma concentration curve
The concentration of a drug in the plasma is a time-dependent function of 
the dose administered. It is a refléction of what the body does to the drug, whereas 
the pharmacologic response is a reflection of what the drug does to the body.
As a rather extreme simplification, the human body may be considered as a 
single compartment into which a certain dose of a drug is introduced (Fig. i). B y 
analogy, such a body compartment may be seen as a reservoir with a certain volume, 
which is continuously cleared at a certain rate by a water flow. Obviously, the initial 
concentration of a drug depends on the dose and the volume of distribution, while the 
elimination rate at any moment depends on the concentration at that moment and 
the clearance (flow).
In Fig. 2, plasma concentration curves are presented, following intravenous or 
oral administration of drugs in human subjects. The points are actual measurements, 
while the curves have been calculated under the assumption that the human body 
may be regarded as a single compartment. From the examples given, it may be
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F ig. i .  Model o f th e clearance of a  substance from  a reservoir w ith  con stan t volum e and a  sche­
m atic presentat'on  o f a  single com partm ent model. D  =  dose; K ei =  elim. clearance constant.
substance in 
freeh water flow ^
F ig. 2. Plasm a concentration  curves following: (a) i.v . adm inistration o f ethylbiscoum acetate 
(Trom exan) to  a  p atiën t4; (b) oral adm inistration o f bu tobarbital to  a  test subject. T he half-live 
calculated from  th e slope o f th e  curve.
seen that relatively large doses were employed and that the time scale may be in 
minutes, hours or days: certain drugs disappear rapidly, whereas others remain in the 
body for a long period of time.
Biological half-life and the fictive volume of distribution
The rate at which a drug is eliminated from the body either by metabolism, 
excretion or both may be characterised by the half value time, t \ .  This time “ constant” 
is defxned as the period of time in which 50% of the drug is eliminated from the 
biological object. It has therefore been called the biological half-life. Obviously, the 
biological half-life will be larger if the volume of distribution is larger and the clearance 
constant is smaller. For a relationship see Table I. It may be noted from this table
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Assum ing th at the hum an body m ay bc regarded as a  single-com partm ental reservoir.
Elim ination process k ei V f t l rt l
Clearance cqual to glome- 
rular filtration from  a 
volum e equal to  the ex- 
tracellular fluid
130 ml/min 
7.8 1/h
12 1 1 h 3 min 1 h 32 min o.o n /m in  
0.65/h
Clearance equal to urine 
flow from  a  volum e equal 
to  to ta l bo d y w ater
0.7 ml/min 
42.0 ml/h 
1.0 1/d
36 1 576 h 
25 d
864 h 
36 d
0.0012/h 
0.040/d
Clearance equal to  renal 
plasm a flow  from  a  vol­
um e equal to  to ta l bo dy 
w ater
700.0 ml/min 
42.0 1/h
36 1 35 min 51 min 0.096/min
1.17/h
Clearance equal to liver 
p lasm a flow from  a  v o l­
um e equal to  th e plasm a 
volum e
1.0 1/min 
60.0 1/h
3 1 2 min 3 min 0.33/min 
20.0/h
Slow  clearance from  a  
large fictive volum e
2 m l /min 
120 ml/h
360 1 2000 h 
89 d
3000 h 
128 d
0.00033/h 
0.0070/d
F ast clearance from  a v e ry  
large fictive volum e
120 ml/min 
7.2 1/h
1440 1 138 h 
5-8 d
200 h
8.3 d
0.0050/h
0.12/d
that the apparent volume of distribution may exceed the volume of the total body 
water. This is because the blood or plasma concentration is the reference point. So, if 
a drug is preferentially taken up in certain tissues, as e.g., muscle or fat, the concen­
tration in such tissues may be p. times the concentration in the blood so that the ap­
parent volume of that particular tissue is p. times the actual volume. On the other 
hand, if a drug binds firmly to plasma proteins the apparent volume of distribution 
may be very small.
The apparent volumes of distribution and the dose determine the concentration 
range in actual plasma which should be determined in order to make a study of the 
kinetic behaviour of a drug possible.
Multicompartment kinetics
When elimination from the body is slow with regard to absorption and distri­
bution, the body may be regarded as a single compartment system. This is then likely 
the case for drugs with a very long half-life. For most drugs the situation is more 
complex or becomes more complex if the plasma curve is followed over a larger con­
centration range.
In general, the body may be seen as a number (n) of compartments which are 
in exchange contact with the first or central compartment, the blood or plasma. The 
plasma concentration then may be described by the sum of a number of exponential 
terms:
Ci =  27 A f •«-*!** (i)
i«=i
Here, Ct is the concentration at a moment t after administration of the drug. Ai is the
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TIME (MINUTES)
F ig. 3. B lood concentration curve  of cyclo barbital in a rat, following i.v . adm inistration. N ote a 
biphasic decay curve.
ith  coëfficiënt and n  the ith time constant. Persistence in the body is thus no longer 
characterised by the biological half-life or a single time constant, but by a number of 
time constants.
In Fig. 3a blood concentration curve of cyclobarbital is given which has been 
determined in a single rat. The curve has been plotted through the measured points 
on basis of a two-compartment model.
In general, the elimination clearance constant k,i may easily be calculated if the 
entire curve is analysed:
kei =  D-Fj Z  Ai-rt (2)
Here D  is the dose of the drug and F  the biological availability or the fraction of the 
dose that ultimately will be absorbed (in case of parenteral administration F  =  1).
It is evident that the entire plasma curve has to be determined in order to 
calculate the clearance constant with sufficiënt accuracy. It is obvious that thelargest 
product At • Ti has the greatest influence on kei. This may be due mainly to a very 
large A t or a very large r t, or both.
Kinetics of drug metabolism
Most drugs are transformed in the body into several metabolites, some of which 
may be pharmacologically active. It is therefore not only important to have some 
knowledge of the kinetics of the drug or toxic agent proper, but also of its active 
metabolites.
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A particular metabolite may be cleared at a higher rate than the parent 
compound and has a smaller fictive volume of distribution. The biological half-life 
of that metabolite is then smaller. Because of the smaller volume of distribution, 
relatively high concentrations may be found. This means that if reasonable con- 
centrations of a metabolite are found, such a substance need not be of importance.
On the other hand the half-life of a metabolite may be longer than that of the 
parent compound either because the clearance is smaller or the apparent volume of 
distribution is larger. Such a situation occurs for e.g. acetosal (t\ =  20 min) (aspirine) 
that is rapidly converted into salicylic acid (t^— 5-6 h), while both parent drug and 
metabolite have a similar volume of distribution of 9 - 1 1 1 (Fig. 4).
Similar situations hold for certain psychotropic drugs, as imipramine {t\ — 3 h) 
that is converted in desipramine {t\ =  approx. 36 h) and diazepam (fy =  approx. 10 h) 
that is converted into desmethyldiazepam (t^ =  approx. 2 days). The active metabol- 
lites formed have structures strongly related to the parent drug. This implies that the 
analytical technique employed should be selective for each substance and preferably 
be carried out in a similar way.
Fig. 4. (a) Plasm a concentration  curve o f acetosal and its m etabolite salicylic acid in a  hum an; 
half-life o f the parent drug and of th e m etabolite5. (b) Plasm a curves of Trom exan and its hydroxy- 
m etabolite4.
Gas-liquid chromatography in pharmacokinetics
As pointed out before, pharmacokinetic parameters may be determined with 
sufficiënt accuracy if the entire plasma concentration curve can be measured. This 
implies that a fairly large number of blood samples should be analysed while the samp­
le size should be kept small (no more than 5 ml in man and less than 0.2 ml in rats). 
As a consequence of the formationof metabolites of related structure and prop-
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erties in the same sample, such metabolites should be determined also quantitatively. 
Except for those drugs that are administered in quantities of the order of grams, the 
concentration range in plasma is low (10 fig/ml and far less). Therefore, highly sensitive 
analytical techniques have to be employed. The gas-liquid chromatographic tech- 
niques using the proper column filling and the proper detector, are rather ideal for this 
purpose.
(a) GLC with flame ionisation detection (fig quantities). For a number of drugs 
this method is excellent. Choosing a good column, carrier gas and oven temperature, a 
large number of samples may be analysed in a short time. The retention time should be 
short enough to assure sufficiently high sensitivity and rapid analysis (dose 100-500 
mg).
For most barbiturates (see Street, this symposium), this method gives very 
good results. Drugs given in much smaller quantities can not be analysed in most 
cases, unless their volume of distribution is very small. For instance, amphetamine 
and diazepam given in 5-25 mg quantities while their volume of distribution is more 
than 200 1, cannot be determined with the flame ionisation detector. This detector is 
not selective, so that in some cases, products normally present in the blood may inter- 
fere.
(b) GLC with a nitrogen detector (ng quantities). Detectors are available that are 
specifically sensitive to substances containing nitrogen action. The selectivity and
ECDatt16
L
F ig. 5. (a) Gas chrom atogram  b y  using electron capture detector o f chlorpheniram ine (B, 4.9 mg) 
added to  th e sam ple and of brom pheniram ine (C) in blood of a subject receiving 8 m g.2 (b) Gas 
chrom atogram  of lynestrenol heptafluorobutyrate, using flam e ionisation detector, (c) E lectron  
cap tu re detector. N ote th e large difference in sensitivity.
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sensitivity are greater than those of the flame ionisation detector. The method may be 
applied to amines and various other bioactive substances1.
(c) GLC with electron capture detector (ng-pg quantities). For drugs that contain 
halogen atoms as in the of case chlorplieniramine, the electron capture detector may be 
used (Fig. 5). Sensitivity is then increased by a factor io-ioo, so that the concentra­
tion of chlorplieniramine (dose 4-12 mg) in the blood may easily be measured2.
For drugs that do not contain halogen or nitro moieties, such moieties have to 
be introduced by quantitative synthesis. Heptafluorobutyric acid and related sub­
stances are frequently used as coupling agents3. See Fig. 5 for a lynestrenol derivative.
F ig. 6. M ass-fragm entogram s of dim ethylam phetam ine and its  m etabolites in th e  urine o f a 
su bject who received dim ethylam phetam ine. A bove: reference com pound; m iddle: characteristic 
mass fragm ent 72 o f d im ethylam phetam ine; below : characteristic mass fragm ent 58 o f the 
m etabolite m etham phetam ine.
Clin. Chim. Acta, 34 (1971) 3 11-3 19
A disadvantage of the electron capture detector is that no large quantity of 
samples can be handled as the detector is easily poisoned. Furthermore, quantitative 
coupling procedures have to be devised for every drug and metabolite that has to be 
analysed.
(d) Mass-fragmentography. A mass spectrometer coupled to a gas chromatograph 
may be used as a detector. (See Brooks, this symposium.) The intensity of certain 
mass lines can be Used as a measure for the amount of a drug. The method is.dependent 
on the mass spectrum, more sensitive than flame-ionisation detection and very 
selective. The method can easily be used for related compounds. For instance, a 
drug and its derivative in which one or more H-atoms are replaced by deuterium, 
may be studied at the same time. In Fig. 6 mass-fragmentograms are given for di- 
methylamphetamine and its metabolites in the urine of a subject to whom the drug 
was administered via the oral route.
This method may also be used to determine the recovery of the extraction and 
purification procedures by adding to the sample an analogue in which deuterium is 
substituted for hydrogen.
(e)  GLC and a detector for radioactive labels. A great problem in the analysis 
of minute amounts of drugs in body fluids is that the purification procedure leads to 
variable losses. This may be controlled by adding a small amount of a highly specific 
radioactive labeled drug to the plasma, so that the recovery of the procedure can be 
checked.
Pharmacokinetic analysis by indirect methods
There are many drugs which are very difficuit to determine in plasma, if very 
low doses are given and the volume of distribution is large.
(a) Urinary excretion data. Information on the biological half-life may be ob- 
tained indirectly by measuring the urinary excretion rate instead of the plasma 
disappearance rate. The renal excretion rate is directly proportional to the plasma 
concentration if certain restrictions are fulfilled. In formula:
Where dQr/dt  is the renal excretion rate and k r is the renal clearance. The quantity 
excreted in the urine over a period of time may be larger by several factors than the 
quantity in a few ml of blood (Fig. 7).
(b) The plateau concentration following chronic administration. Chronic admini­
stration of a drug may result in accumulation if per unit of time more drug is absorbed 
than is eliminated. As a result, concentration may increase considerably. However, 
after a sufficiently long period of time, the concentration does not increase further and 
a plateau is reached. The concentration in the accumulation plateau is a simple 
relation to the dose and the dosage interval {dAt) :
Cpi =  D-FIAt • kei
Therefore, without following the entire plasma curve, the clearance constant may be 
determined directly from the concentration in the plateau. Since this concentration is 
much higher than the maximum of the curve following a single dose, accumulation 
plateau concentrations may be studied initially.
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F ig. 7. B lood concentration curve of isopropyl-am phctam ine in a  hum an subject sim ultaneously 
w ith  th e concentration in the saliva, w hich is alm ost 10 tim es higher, and the renal excretion rate 
curve. N ote th at the curves run parallel so th a t th e biological half-life m ay be calculated from  
the urin ary d ata  alone.
Conclusions
Blood and tissue concentrations of most drugs may be determined with GLC 
procedures.
In addition to the use of the flame ionisation detector and columns of a size 
normal for drugs given in reasonable doses (100-1000 mg), the combined GLC-mass 
spectrometry may be of extremely great help for the rapid and selective analysis of 
minute quantities of drugs and their metabolites.
The extraction and purification procedures prior to GLC separation in general 
set a limit to the sensitivity, unless recovery can be brought under control.
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